Pharmacy Retail
Quarterly Result28 March 2026 at 11:51 am

Medplus Health Services Ltd to Approve Q4 and FY2025-26 Financial Results on May 29, 2026

AI Summary

Medplus Health Services Ltd has announced that its Board of Directors will meet on May 29, 2026, to consider and approve the audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The results will be submitted to the Stock Exchanges after the board meeting and will be hosted on the company's website and published in newspapers as per the SEBI (LODR) Regulations, 2015. The trading window for Designated Persons of the company, including their immediate relatives, will be closed from April 01, 2026, to May 31, 2026, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prevention of Insider Trading.

Key Highlights

  • Medplus Health Services Ltd to approve Q4 and FY2025-26 financial results on May 29, 2026
  • Results to be submitted to Stock Exchanges after the board meeting
  • Results to be hosted on the company's website and published in newspapers
  • Trading window for Designated Persons and their immediate relatives to be closed from April 01, 2026, to May 31, 2026